Takayasu, Kenta, Koei Muguruma, and Hidefumi Kinoshita. “Durable Complete Response to Combination Nivolumab and Ipilimumab in Metastatic Renal Cell Carcinoma”. Trends in Immunotherapy 6, no. 1 (January 14, 2022). Accessed April 3, 2025. https://ojs.ukscip.com/index.php/ti/article/view/426.